在ALS中使用外部对照对甲基酸和陶尔苏醇生存效应的分析
Sabrina Paganoni1,2, Melanie Quintana3, Alexander V Sherman1
1Sean M. Healey and AMG Center for ALS & the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Annals of clinical and translational neurology
|October 9, 2023
概括
phenylbutyrate 和 taurursodiol (PB 和 TURSO) 在肌缩性侧面硬化症 (ALS) 患者中显示出显著的生存益处. 与以前的分析相比,这种联合治疗可能会提供更大的生存优势.
科学领域:
- 神经科学是一个神经科学.
- 临床药理学 临床药理学
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种进展性神经退行性疾病,治疗选择有限.
- phenylbutyrate 和 taurursodiol (PB 和 TURSO) 是一种针对ALS的研究疗法.
研究的目的:
- 为了评估PB和TURSO在ALS患者的生存益处,使用倾向性得分匹配的外部对照队列.
- 为了估计PB和TURSO的治疗效果,而没有安慰剂与活性药物交叉的混因素.
主要方法:
- 进行了后期生存分析,比较了来自CENTAUR试验的PB和TURSO治疗患者与来自PRO-ACT数据库的匹配外部对照组.
- 使用倾向性得分匹配,以根据关键预后共变量确保治疗组和对照组之间的可比性.
主要成果:
- 在PB和TURSO组 (n=89) 中,总生存时间 (OS) 的中位数为23.54个月,而在外部对照组 (n=85) 中为13.15个月.
- 在PB和TURSO组中观察到死亡风险降低了52% (危险比,0.48;95%CI,0.31-0.72;p=0.00048).
结论:
- 这项分析表明,当混杂因素 (如交叉) 被最小化时,PB和TURSO在ALS中的生存益处可能更大.
- 使用匹配的外部对照可以在未来的ALS临床试验中为评估生存效应提供有价值的背景.
相关概念视频
01:20Comparing the Survival Analysis of Two or More Groups
206
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
206
01:15Assumptions of Survival Analysis
150
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
150
01:18Introduction To Survival Analysis
258
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
258